Zdrowie i gospodarka · 01/07/2016
FDA Releases Revised Draft Guidance for Generic Paliperidone Palmitate
The FDA has made a revised draft guidance for industry available, outlining specific recommendations for bioequivalence studies to support generic applications for paliperidone palmitate extended-release injectable suspension.